Clinical Pharmacology for the Office of Medicare Hearings and Appeals

The Department of Health and Human Services Office of the Assistant Secretary for Administration, procuring on behalf of the Office of Medicare Hearings and Appeals, intends to award a sole-source contract for 32 Clinical Pharmacology Compendia Licenses Subscriptions, with responses due by June 23, 2026 at 12:00 p.m. Eastern Time.

The procurement is noncompetitive under FAR 13.106-1(b) based on Medicare Part B regulations that designate Elsevier's Clinical Pharmacology compendium as the exclusively approved national drug compendium for determining anti-cancer drug therapy coverage. Administrative Law Judges and attorneys require access to this resource to make coverage determinations on anti-cancer medications. The compendium provides access to drug information on more than 50,000 medication products, including FDA-approved prescription medicines, over-the-counter medicines, dietary supplements, and investigational drug agents, with comprehensive coverage of drugs and biologics used in cancer treatment and management.

The period of performance consists of a 12-month base period and four optional 12-month renewal periods. All responsible sources may submit responses demonstrating clear and convincing evidence of capability to fulfill the requirement. Respondents must submit the DUNS Number, Unique Entity Identifier, Taxpayer Identification Number, business size certification, and maintain active SAM registration. Submissions should be directed to azeb.mengistu@hhs.gov, referencing announcement number REQT-OMAS-PS-2026-00010. The incumbent contractor is Elsevier Inc., located at 230 Park Avenue, Floor 8, New York, NY 10169.